A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAZZOTTI, Tatiane Katsue Furuya et al. Bases da biologia molecular. Genômica e marcadores moleculares em gastroenterologia e hepatologia. São Paulo: Sarvier. . Acesso em: 06 set. 2024. , 2017
APA
Mazzotti, T. K. F., Leal, M. F., Cirilo, P. D. R., & Chammas, R. (2017). Bases da biologia molecular. Genômica e marcadores moleculares em gastroenterologia e hepatologia. São Paulo: Sarvier.
NLM
Mazzotti TKF, Leal MF, Cirilo PDR, Chammas R. Bases da biologia molecular. Genômica e marcadores moleculares em gastroenterologia e hepatologia. 2017 ;[citado 2024 set. 06 ]
Vancouver
Mazzotti TKF, Leal MF, Cirilo PDR, Chammas R. Bases da biologia molecular. Genômica e marcadores moleculares em gastroenterologia e hepatologia. 2017 ;[citado 2024 set. 06 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clinical and Experimental Medicine, v. 15, n. 3, p. 415-420, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10238-014-0299-0. Acesso em: 06 set. 2024.
APA
Leal, M. F., Calcagno, D. Q., Chung, J., Freitas, V. M., Demachki, S., Assumpção, P. P., et al. (2015). Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clinical and Experimental Medicine, 15( 3), 415-420. doi:10.1007/s10238-014-0299-0
NLM
Leal MF, Calcagno DQ, Chung J, Freitas VM, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients [Internet]. Clinical and Experimental Medicine. 2015 ; 15( 3): 415-420.[citado 2024 set. 06 ] Available from: https://doi.org/10.1007/s10238-014-0299-0
Vancouver
Leal MF, Calcagno DQ, Chung J, Freitas VM, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients [Internet]. Clinical and Experimental Medicine. 2015 ; 15( 3): 415-420.[citado 2024 set. 06 ] Available from: https://doi.org/10.1007/s10238-014-0299-0
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3′ Untranslated Region 1630 C>T Polymorphism and Copy Number Variation. PLOS ONE, v. 9, n. 5, p. 9 art. e98583, 2014Tradução . . Disponível em: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098583&representation=PDF. Acesso em: 06 set. 2024.
APA
Leal, M. F., Cirilo, P. D. R., Mazzotti, T. K. F., Calcagno, D. Q., Wisnieski, F., Demachki, S., et al. (2014). Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3′ Untranslated Region 1630 C>T Polymorphism and Copy Number Variation. PLOS ONE, 9( 5), 9 art. e98583. doi:10.1371/journal.pone.0098583
NLM
Leal MF, Cirilo PDR, Mazzotti TKF, Calcagno DQ, Wisnieski F, Demachki S, Martinez MC, Assumpção PP, Chammas R, Burbano RR, Smith MC. Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3′ Untranslated Region 1630 C>T Polymorphism and Copy Number Variation [Internet]. PLOS ONE. 2014 ; 9( 5): 9 art. e98583.[citado 2024 set. 06 ] Available from: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098583&representation=PDF
Vancouver
Leal MF, Cirilo PDR, Mazzotti TKF, Calcagno DQ, Wisnieski F, Demachki S, Martinez MC, Assumpção PP, Chammas R, Burbano RR, Smith MC. Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3′ Untranslated Region 1630 C>T Polymorphism and Copy Number Variation [Internet]. PLOS ONE. 2014 ; 9( 5): 9 art. e98583.[citado 2024 set. 06 ] Available from: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098583&representation=PDF
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications. BMC Gastroenterology, v. 19, n. 9, p. 10 , 2014Tradução . . Disponível em: http://www.biomedcentral.com/1471-230X/14/9. Acesso em: 06 set. 2024.
APA
Leal, M. F., Mazzotti, T. K. F., Calcagno, D. Q., Cirilo, P. D. R., Martinez, M. C., Demachki, S., et al. (2014). Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications. BMC Gastroenterology, 19( 9), 10 . doi:10.1186/1471-230X-14-9
NLM
Leal MF, Mazzotti TKF, Calcagno DQ, Cirilo PDR, Martinez MC, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications [Internet]. BMC Gastroenterology. 2014 ; 19( 9): 10 .[citado 2024 set. 06 ] Available from: http://www.biomedcentral.com/1471-230X/14/9
Vancouver
Leal MF, Mazzotti TKF, Calcagno DQ, Cirilo PDR, Martinez MC, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications [Internet]. BMC Gastroenterology. 2014 ; 19( 9): 10 .[citado 2024 set. 06 ] Available from: http://www.biomedcentral.com/1471-230X/14/9
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Clinical implication of 14-3-3 epsilon expression in gastric cancer. World Journal of Gastroenterology, v. 18, n. 13, p. 1531-1537, 2012Tradução . . Disponível em: https://doi.org/10.3748/wjg.v18.i13.1531. Acesso em: 06 set. 2024.
APA
Leal, M. F., Calcagno, D. Q., Demachki, S., Assumpção, P. P., Chammas, R., Burbano, R. R., & Smith, M. de A. C. (2012). Clinical implication of 14-3-3 epsilon expression in gastric cancer. World Journal of Gastroenterology, 18( 13), 1531-1537. doi:10.3748/wjg.v18.i13.1531
NLM
Leal MF, Calcagno DQ, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith M de AC. Clinical implication of 14-3-3 epsilon expression in gastric cancer [Internet]. World Journal of Gastroenterology. 2012 ; 18( 13): 1531-1537.[citado 2024 set. 06 ] Available from: https://doi.org/10.3748/wjg.v18.i13.1531
Vancouver
Leal MF, Calcagno DQ, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith M de AC. Clinical implication of 14-3-3 epsilon expression in gastric cancer [Internet]. World Journal of Gastroenterology. 2012 ; 18( 13): 1531-1537.[citado 2024 set. 06 ] Available from: https://doi.org/10.3748/wjg.v18.i13.1531